Elevated expression of cd80 (b7/bb1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis
- 1 November 1994
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (11), 1637-1646
- https://doi.org/10.1002/art.1780371113
Abstract
Objective. To assess the expression of important accessory molecules such as CD80 (B7/BB1) and CD54 (intercellular adhesion molecule 1) on potential antigen‐presenting cells (APC) in the synovial fluid (SF) of patients with rheumatoid arthritis (RA). Methods. The level of expression of various accessory molecules on T cells, monocytes, and CD5+ or CD5– B cells from RA SF was compared, by multiparameter flow cytometric analysis, with the expression on peripheral blood (PB) mononuclear cells from the same patients and from normal controls. The functional significance of increased expression of these accessory molecules was assessed by the ability of the different cell populations to stimulate T cells in the mixed lymphocyte reaction. Results. Monocytes, T cells, and B cells isolated from the SF of inflamed joints of patients with RA expressed significantly higher levels of CD80 and CD54 than those from the PB of RA patients or normal controls. CD11b and CD11c expression also were increased on SF B cells, while SF monocytes exhibited enhanced levels of CD40. Further, we found that the elevated CD80 and CD54 levels in RA SF cells may enhance the capacity of these cells to act as stimulatory APC. Conclusion. This is the first demonstration that specific cell subsets constitutively express increased levels of CD80 at a site of autoimmune pathology, which could potentially contribute to the initiation or maintenance of autoimmune disease.Keywords
This publication has 50 references indexed in Scilit:
- The B7 adhesion molecule is expressed on activated human T cells: Functional involvement in T‐T cell interactionsEuropean Journal of Immunology, 1993
- CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activationImmunology Today, 1992
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18.The Journal of Experimental Medicine, 1991
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Expression of Activation Antigens on T Cells in Rheumatoid Arthritis PatientsScandinavian Journal of Immunology, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Studies of rheumatoid synovial fluid lymphocytesClinical Immunology and Immunopathology, 1983